Dr Reddy’s Laboratories on Friday mentioned it has launched an over-the-counter generic medicine for aid from nasal and sinus congestion on account of colds or allergy symptoms.
The Hyderabad-based drug agency mentioned it has launched Fexofenadine HCl 180 mg and Pseudoephedrine HCl 240 mg prolonged launch tablets within the US market.
The drug agency mentioned it has launched the drug, which is equal of Aventisub LLC’s Allegra-D 24 HR, after getting approval from the US Meals and Drug Administration (USFDA).
”The launch of firm’s Fexofenadine HCl 180 mg and Pseudoephedrine HCl 240 mg Prolonged Launch Tablets, USP, is a crucial addition to our higher respiratory portfolio of OTC merchandise,” Dr Reddy’s Laboratories North America Generics CEO Marc Kikuchi mentioned.
This primary-to-market launch is a testomony to firm’s deep capabilities and continued efforts to convey top quality, inexpensive store-brand alternate options for patrons and sufferers, he added.
The corporate mentioned its medicine might be obtainable in 5-count, 10-count, and 15-count pack sizes.
Dr Reddy’s product is an over-the-counter oral antihistamine and nasal decongestant for the momentary aid of nasal and sinus congestion on account of colds or allergy symptoms.
It offers momentary aid from sneezing, runny nostril, itchy, watery eyes and itchy nostril or throat on account of allergy symptoms.
In keeping with IRI, Allegra-D 24 HR had retail gross sales of round USD 45 million within the US.